Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer
This study aims to assess age-related treatment patterns and primary reasons for adjusted treatment in patients with colorectal cancer.
Gespeichert in:
| Autor*in: |
Scheepers, E.R.M. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus - Wang, Hui ELSEVIER, 2022, Burlington, Mass |
|---|---|
| Übergeordnetes Werk: |
volume:47 ; year:2021 ; number:7 ; pages:1675-1682 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ejso.2021.01.029 |
|---|
| Katalog-ID: |
ELV054407400 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV054407400 | ||
| 003 | DE-627 | ||
| 005 | 20230624211139.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejso.2021.01.029 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001422.pica |
| 035 | |a (DE-627)ELV054407400 | ||
| 035 | |a (ELSEVIER)S0748-7983(21)00059-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.45 |2 bkl | ||
| 100 | 1 | |a Scheepers, E.R.M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer |
| 264 | 1 | |c 2021 | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a This study aims to assess age-related treatment patterns and primary reasons for adjusted treatment in patients with colorectal cancer. | ||
| 650 | 7 | |a Reasons adjusted treatment |2 Elsevier | |
| 650 | 7 | |a Colorectal cancer |2 Elsevier | |
| 650 | 7 | |a Guideline-adherence |2 Elsevier | |
| 650 | 7 | |a Older patients |2 Elsevier | |
| 650 | 7 | |a Treatment patterns |2 Elsevier | |
| 700 | 1 | |a Schiphorst, A.H. |4 oth | |
| 700 | 1 | |a van Huis-Tanja, L.H. |4 oth | |
| 700 | 1 | |a Emmelot-Vonk, M.H. |4 oth | |
| 700 | 1 | |a Hamaker, M.E. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Harcourt |a Wang, Hui ELSEVIER |t Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |d 2022 |g Burlington, Mass |w (DE-627)ELV008984085 |
| 773 | 1 | 8 | |g volume:47 |g year:2021 |g number:7 |g pages:1675-1682 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejso.2021.01.029 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.45 |j Immunologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 47 |j 2021 |e 7 |h 1675-1682 |g 8 | ||
| author_variant |
e s es |
|---|---|
| matchkey_str |
scheepersermschiphorstahvanhuistanjalhem:2021----:ramnptenadrmrraosoajsetetetnleadoneptetw |
| hierarchy_sort_str |
2021 |
| bklnumber |
44.45 |
| publishDate |
2021 |
| allfields |
10.1016/j.ejso.2021.01.029 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001422.pica (DE-627)ELV054407400 (ELSEVIER)S0748-7983(21)00059-7 DE-627 ger DE-627 rakwb eng 610 VZ 44.45 bkl Scheepers, E.R.M. verfasserin aut Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier This study aims to assess age-related treatment patterns and primary reasons for adjusted treatment in patients with colorectal cancer. Reasons adjusted treatment Elsevier Colorectal cancer Elsevier Guideline-adherence Elsevier Older patients Elsevier Treatment patterns Elsevier Schiphorst, A.H. oth van Huis-Tanja, L.H. oth Emmelot-Vonk, M.H. oth Hamaker, M.E. oth Enthalten in Harcourt Wang, Hui ELSEVIER Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus 2022 Burlington, Mass (DE-627)ELV008984085 volume:47 year:2021 number:7 pages:1675-1682 extent:8 https://doi.org/10.1016/j.ejso.2021.01.029 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 47 2021 7 1675-1682 8 |
| spelling |
10.1016/j.ejso.2021.01.029 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001422.pica (DE-627)ELV054407400 (ELSEVIER)S0748-7983(21)00059-7 DE-627 ger DE-627 rakwb eng 610 VZ 44.45 bkl Scheepers, E.R.M. verfasserin aut Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier This study aims to assess age-related treatment patterns and primary reasons for adjusted treatment in patients with colorectal cancer. Reasons adjusted treatment Elsevier Colorectal cancer Elsevier Guideline-adherence Elsevier Older patients Elsevier Treatment patterns Elsevier Schiphorst, A.H. oth van Huis-Tanja, L.H. oth Emmelot-Vonk, M.H. oth Hamaker, M.E. oth Enthalten in Harcourt Wang, Hui ELSEVIER Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus 2022 Burlington, Mass (DE-627)ELV008984085 volume:47 year:2021 number:7 pages:1675-1682 extent:8 https://doi.org/10.1016/j.ejso.2021.01.029 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 47 2021 7 1675-1682 8 |
| allfields_unstemmed |
10.1016/j.ejso.2021.01.029 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001422.pica (DE-627)ELV054407400 (ELSEVIER)S0748-7983(21)00059-7 DE-627 ger DE-627 rakwb eng 610 VZ 44.45 bkl Scheepers, E.R.M. verfasserin aut Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier This study aims to assess age-related treatment patterns and primary reasons for adjusted treatment in patients with colorectal cancer. Reasons adjusted treatment Elsevier Colorectal cancer Elsevier Guideline-adherence Elsevier Older patients Elsevier Treatment patterns Elsevier Schiphorst, A.H. oth van Huis-Tanja, L.H. oth Emmelot-Vonk, M.H. oth Hamaker, M.E. oth Enthalten in Harcourt Wang, Hui ELSEVIER Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus 2022 Burlington, Mass (DE-627)ELV008984085 volume:47 year:2021 number:7 pages:1675-1682 extent:8 https://doi.org/10.1016/j.ejso.2021.01.029 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 47 2021 7 1675-1682 8 |
| allfieldsGer |
10.1016/j.ejso.2021.01.029 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001422.pica (DE-627)ELV054407400 (ELSEVIER)S0748-7983(21)00059-7 DE-627 ger DE-627 rakwb eng 610 VZ 44.45 bkl Scheepers, E.R.M. verfasserin aut Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier This study aims to assess age-related treatment patterns and primary reasons for adjusted treatment in patients with colorectal cancer. Reasons adjusted treatment Elsevier Colorectal cancer Elsevier Guideline-adherence Elsevier Older patients Elsevier Treatment patterns Elsevier Schiphorst, A.H. oth van Huis-Tanja, L.H. oth Emmelot-Vonk, M.H. oth Hamaker, M.E. oth Enthalten in Harcourt Wang, Hui ELSEVIER Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus 2022 Burlington, Mass (DE-627)ELV008984085 volume:47 year:2021 number:7 pages:1675-1682 extent:8 https://doi.org/10.1016/j.ejso.2021.01.029 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 47 2021 7 1675-1682 8 |
| allfieldsSound |
10.1016/j.ejso.2021.01.029 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001422.pica (DE-627)ELV054407400 (ELSEVIER)S0748-7983(21)00059-7 DE-627 ger DE-627 rakwb eng 610 VZ 44.45 bkl Scheepers, E.R.M. verfasserin aut Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier This study aims to assess age-related treatment patterns and primary reasons for adjusted treatment in patients with colorectal cancer. Reasons adjusted treatment Elsevier Colorectal cancer Elsevier Guideline-adherence Elsevier Older patients Elsevier Treatment patterns Elsevier Schiphorst, A.H. oth van Huis-Tanja, L.H. oth Emmelot-Vonk, M.H. oth Hamaker, M.E. oth Enthalten in Harcourt Wang, Hui ELSEVIER Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus 2022 Burlington, Mass (DE-627)ELV008984085 volume:47 year:2021 number:7 pages:1675-1682 extent:8 https://doi.org/10.1016/j.ejso.2021.01.029 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 47 2021 7 1675-1682 8 |
| language |
English |
| source |
Enthalten in Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus Burlington, Mass volume:47 year:2021 number:7 pages:1675-1682 extent:8 |
| sourceStr |
Enthalten in Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus Burlington, Mass volume:47 year:2021 number:7 pages:1675-1682 extent:8 |
| format_phy_str_mv |
Article |
| bklname |
Immunologie |
| institution |
findex.gbv.de |
| topic_facet |
Reasons adjusted treatment Colorectal cancer Guideline-adherence Older patients Treatment patterns |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |
| authorswithroles_txt_mv |
Scheepers, E.R.M. @@aut@@ Schiphorst, A.H. @@oth@@ van Huis-Tanja, L.H. @@oth@@ Emmelot-Vonk, M.H. @@oth@@ Hamaker, M.E. @@oth@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV008984085 |
| dewey-sort |
3610 |
| id |
ELV054407400 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV054407400</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624211139.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejso.2021.01.029</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001422.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV054407400</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0748-7983(21)00059-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Scheepers, E.R.M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This study aims to assess age-related treatment patterns and primary reasons for adjusted treatment in patients with colorectal cancer.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Reasons adjusted treatment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Colorectal cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Guideline-adherence</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Older patients</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Treatment patterns</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schiphorst, A.H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">van Huis-Tanja, L.H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Emmelot-Vonk, M.H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hamaker, M.E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Wang, Hui ELSEVIER</subfield><subfield code="t">Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus</subfield><subfield code="d">2022</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV008984085</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:47</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:7</subfield><subfield code="g">pages:1675-1682</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejso.2021.01.029</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">47</subfield><subfield code="j">2021</subfield><subfield code="e">7</subfield><subfield code="h">1675-1682</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| author |
Scheepers, E.R.M. |
| spellingShingle |
Scheepers, E.R.M. ddc 610 bkl 44.45 Elsevier Reasons adjusted treatment Elsevier Colorectal cancer Elsevier Guideline-adherence Elsevier Older patients Elsevier Treatment patterns Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer |
| authorStr |
Scheepers, E.R.M. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008984085 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.45 bkl Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer Reasons adjusted treatment Elsevier Colorectal cancer Elsevier Guideline-adherence Elsevier Older patients Elsevier Treatment patterns Elsevier |
| topic |
ddc 610 bkl 44.45 Elsevier Reasons adjusted treatment Elsevier Colorectal cancer Elsevier Guideline-adherence Elsevier Older patients Elsevier Treatment patterns |
| topic_unstemmed |
ddc 610 bkl 44.45 Elsevier Reasons adjusted treatment Elsevier Colorectal cancer Elsevier Guideline-adherence Elsevier Older patients Elsevier Treatment patterns |
| topic_browse |
ddc 610 bkl 44.45 Elsevier Reasons adjusted treatment Elsevier Colorectal cancer Elsevier Guideline-adherence Elsevier Older patients Elsevier Treatment patterns |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a s as h t l v htl htlv m e v mev m h mh |
| hierarchy_parent_title |
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |
| hierarchy_parent_id |
ELV008984085 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008984085 |
| title |
Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer |
| ctrlnum |
(DE-627)ELV054407400 (ELSEVIER)S0748-7983(21)00059-7 |
| title_full |
Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer |
| author_sort |
Scheepers, E.R.M. |
| journal |
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |
| journalStr |
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
1675 |
| author_browse |
Scheepers, E.R.M. |
| container_volume |
47 |
| physical |
8 |
| class |
610 VZ 44.45 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Scheepers, E.R.M. |
| doi_str_mv |
10.1016/j.ejso.2021.01.029 |
| dewey-full |
610 |
| title_sort |
treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage ii or iii colorectal cancer |
| title_auth |
Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer |
| abstract |
This study aims to assess age-related treatment patterns and primary reasons for adjusted treatment in patients with colorectal cancer. |
| abstractGer |
This study aims to assess age-related treatment patterns and primary reasons for adjusted treatment in patients with colorectal cancer. |
| abstract_unstemmed |
This study aims to assess age-related treatment patterns and primary reasons for adjusted treatment in patients with colorectal cancer. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
7 |
| title_short |
Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer |
| url |
https://doi.org/10.1016/j.ejso.2021.01.029 |
| remote_bool |
true |
| author2 |
Schiphorst, A.H. van Huis-Tanja, L.H. Emmelot-Vonk, M.H. Hamaker, M.E. |
| author2Str |
Schiphorst, A.H. van Huis-Tanja, L.H. Emmelot-Vonk, M.H. Hamaker, M.E. |
| ppnlink |
ELV008984085 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth |
| doi_str |
10.1016/j.ejso.2021.01.029 |
| up_date |
2024-07-06T21:38:43.334Z |
| _version_ |
1803867309562920960 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV054407400</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624211139.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejso.2021.01.029</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001422.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV054407400</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0748-7983(21)00059-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Scheepers, E.R.M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment patterns and primary reasons for adjusted treatment in older and younger patients with stage II or III colorectal cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This study aims to assess age-related treatment patterns and primary reasons for adjusted treatment in patients with colorectal cancer.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Reasons adjusted treatment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Colorectal cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Guideline-adherence</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Older patients</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Treatment patterns</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schiphorst, A.H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">van Huis-Tanja, L.H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Emmelot-Vonk, M.H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hamaker, M.E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Wang, Hui ELSEVIER</subfield><subfield code="t">Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus</subfield><subfield code="d">2022</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV008984085</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:47</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:7</subfield><subfield code="g">pages:1675-1682</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejso.2021.01.029</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">47</subfield><subfield code="j">2021</subfield><subfield code="e">7</subfield><subfield code="h">1675-1682</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| score |
7.400174 |